Nwam LLC lifted its stake in Cameco Co. (NYSE:CCJ - Free Report) TSE: CCO by 10.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 70,632 shares of the basic materials company's stock after acquiring an additional 6,502 shares during the period. Nwam LLC's holdings in Cameco were worth $3,630,000 at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in CCJ. Sierra Ocean LLC purchased a new position in shares of Cameco during the fourth quarter worth about $25,000. Whipplewood Advisors LLC bought a new stake in shares of Cameco in the 4th quarter worth approximately $33,000. Pingora Partners LLC bought a new position in shares of Cameco during the 3rd quarter valued at $33,000. Compass Planning Associates Inc purchased a new position in Cameco in the 4th quarter worth $36,000. Finally, First Horizon Advisors Inc. lifted its stake in Cameco by 84.2% in the third quarter. First Horizon Advisors Inc. now owns 768 shares of the basic materials company's stock worth $37,000 after purchasing an additional 351 shares during the last quarter. 70.21% of the stock is currently owned by hedge funds and other institutional investors.
Cameco Trading Up 1.3 %
Cameco stock traded up $0.56 during trading hours on Friday, reaching $44.04. The stock had a trading volume of 3,134,810 shares, compared to its average volume of 4,710,722. The stock has a market cap of $19.17 billion, a PE ratio of 157.27 and a beta of 0.94. The company has a fifty day simple moving average of $49.87 and a 200-day simple moving average of $49.91. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.88 and a quick ratio of 1.26. Cameco Co. has a 52 week low of $35.43 and a 52 week high of $62.55.
Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last announced its quarterly earnings results on Thursday, February 20th. The basic materials company reported $0.26 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.26. Cameco had a return on equity of 4.34% and a net margin of 5.39%. The company had revenue of $845.54 million for the quarter, compared to the consensus estimate of $1.09 billion. Analysts forecast that Cameco Co. will post 1.27 EPS for the current fiscal year.
Analysts Set New Price Targets
Separately, StockNews.com raised Cameco from a "sell" rating to a "hold" rating in a research note on Friday, February 21st. One equities research analyst has rated the stock with a hold rating, five have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, Cameco presently has a consensus rating of "Buy" and a consensus price target of $66.56.
View Our Latest Analysis on Cameco
About Cameco
(
Free Report)
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Read More

Before you consider Cameco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.
While Cameco currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.